Aries Wealth Management Sells 60 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Aries Wealth Management cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,341 shares of the healthcare conglomerate’s stock after selling 60 shares during the period. Aries Wealth Management’s holdings in UnitedHealth Group were worth $2,196,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $37,000. Friedenthal Financial bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $51,000. Highline Wealth Partners LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $55,000. Finally, Legacy Investment Solutions LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at $57,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $531.31 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock’s 50-day moving average is $524.58 and its 200 day moving average is $563.71. The stock has a market cap of $488.95 billion, a price-to-earnings ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on UNH shares. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens raised their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.